{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:28:53Z","timestamp":1785882533477,"version":"3.56.0"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2022,1,3]],"date-time":"2022-01-03T00:00:00Z","timestamp":1641168000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:p>Primary central nervous system lymphoma (PCNSL) of peripheral T-cell lineage (T-PCNSL) is rare, and its genetic and clinicopathologic features remain unclear. Here, we present 11 cases of T-PCNSL in immunocompetent individuals from a single institute, focusing on their genetic alterations. Seven cases were subject to targeted panel sequencing covering 120 lymphoma-related genes. Nine of the eleven cases were classified as peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), of which one was of \u03b3\u03b4T-cell lineage. There was one case of anaplastic lymphoma kinase-positive anaplastic large cell lymphoma and another of extranodal natural killer (NK)\/T-cell lymphoma (ENKTL) of \u03b1\u03b2T-cell lineage. The male to female ratio was 7 : 4 and the age ranged from 3 to 75 years (median, 61\u2009y). Most patients presented with neurological deficits (n=10) and showed multifocal lesions (n=9) and deep brain structure involvement (n=9). Tumor cells were mostly small-to-medium, and T-cell monoclonality was detected in all nine evaluated cases. PTCL-NOS was CD4-positive (n=4), CD8-positive (n=3), mixed CD4-positive and CD8-positive (n=1), or CD4\/CD8-double-negative (n=1, \u03b3\u03b4T-cell type). Cytotoxic molecule expression was observed in 4 (67%) of the 6 evaluated cases. Pathogenic alterations were found in 4 patients: one PTCL-NOS case had a frameshift mutation in <jats:italic toggle=\"yes\">KMT2C<\/jats:italic>, another PTCL-NOS case harbored a truncating mutation in <jats:italic toggle=\"yes\">TET2<\/jats:italic>, and another (\u03b3\u03b4T-cell-PTCL-NOS) harbored <jats:italic toggle=\"yes\">NRAS<\/jats:italic> G12S and <jats:italic toggle=\"yes\">JAK3<\/jats:italic> M511I mutations, and homozygous deletions of <jats:italic toggle=\"yes\">CDKN2A<\/jats:italic> and <jats:italic toggle=\"yes\">CDKN2B<\/jats:italic>. The ENKTL (\u03b1\u03b2T-cell lineage) case harbored mutations in genes <jats:italic toggle=\"yes\">ARID1B<\/jats:italic>, <jats:italic toggle=\"yes\">FAS<\/jats:italic>, <jats:italic toggle=\"yes\">TP53<\/jats:italic>, <jats:italic toggle=\"yes\">BCOR<\/jats:italic>, <jats:italic toggle=\"yes\">KMT2C<\/jats:italic>, <jats:italic toggle=\"yes\">POT1<\/jats:italic>, and <jats:italic toggle=\"yes\">PRDM1.<\/jats:italic> In conclusion, most of the T-PCNSL were PTCL-NOS, but sporadic cases of other subtypes including \u03b3\u03b4T-cell lymphoma, anaplastic lymphoma kinase-positive anaplastic large cell lymphoma, and ENKTL were also encountered. Immunophenotypic analysis, clonality test, and targeted gene sequencing along with clinicoradiologic evaluation, may be helpful for establishing the diagnosis of T-PCNSL. Moreover, this study demonstrates genetic alterations with potential diagnostic and therapeutic utility in T-PCNSL.<\/jats:p>","DOI":"10.1097\/pas.0000000000001859","type":"journal-article","created":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T08:00:45Z","timestamp":1641283245000},"page":"486-497","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Clinicopathologic and Genetic Features of Primary T-cell Lymphomas of the Central Nervous System"],"prefix":"10.1097","volume":"46","author":[{"given":"Jeemin","family":"Yim","sequence":"first","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiwon","family":"Koh","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Center for Precision Medicine, Seoul National University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehui","family":"Kim","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Department of Pathology, Severance Hospital, Yonsei University College of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Geun","family":"Song","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong Mo","family":"Bae","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Center for Precision Medicine, Seoul National University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongseok","family":"Yun","sequence":"additional","affiliation":[{"name":"Center for Precision Medicine, Seoul National University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Youn","family":"Sung","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kyung Hee University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Min","family":"Kim","sequence":"additional","affiliation":[{"name":"Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine"},{"name":"Cancer Research Institute, Seoul National University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-Hye","family":"Park","sequence":"additional","affiliation":[{"name":"Pathology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Kyung","family":"Jeon","sequence":"additional","affiliation":[{"name":"Pathology"},{"name":"Cancer Research Institute, Seoul National University, Seoul, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,1,3]]},"reference":[{"key":"R2-20250612","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1212\/WNL.58.10.1513","article-title":"A multicenter study of treatment of primary CNS lymphoma","volume":"58","author":"Ferreri","year":"2002","journal-title":"Neurology"},{"key":"R3-20250612","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3171\/jns.2000.92.2.0261","article-title":"Primary intracerebral malignant lymphoma: report of 248 cases","volume":"92","author":"Bataille","year":"2000","journal-title":"J Neurosurg"},{"key":"R4-20250612","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0360-3016(98)00564-1","article-title":"Primary central nervous system lymphoma in Japan: a nationwide survey","volume":"44","author":"Hayabuchi","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R5-20250612","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1007\/s00277-011-1225-0","article-title":"Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes","volume":"90","author":"Lim","year":"2011","journal-title":"Ann Hematol"},{"key":"R6-20250612","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1200\/JCO.2005.07.109","article-title":"Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative group","volume":"23","author":"Shenkier","year":"2005","journal-title":"J Clin Oncol"},{"key":"R7-20250612","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1097\/PAS.0000000000000503","article-title":"Primary CNS T-cell lymphomas: a clinical, morphologic, immunophenotypic, and molecular analysis","volume":"39","author":"Menon","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R8-20250612","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4132\/jptm.2018.08.21","article-title":"Primary peripheral gamma delta T-cell lymphoma of the central nervous system: report of a case involving the intramedullary spinal cord and presenting with myelopathy","volume":"53","author":"Yim","year":"2019","journal-title":"J Pathol Transl Med"},{"key":"R9-20250612","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0002-9440(10)65252-2","article-title":"Detection of clonal T-cell receptor gamma gene rearrangements in paraffin-embedded tissue by polymerase chain reaction and nonradioactive single-strand conformational polymorphism analysis","volume":"154","author":"Signoretti","year":"1999","journal-title":"Am J Pathol"},{"key":"R10-20250612","doi-asserted-by":"crossref","first-page":"e46821","DOI":"10.15252\/embr.201846821","article-title":"The lysine-specific methyltransferase KMT2C\/MLL3 regulates DNA repair components in cancer","volume":"20","author":"Rampias","year":"2019","journal-title":"EMBO Rep"},{"key":"R11-20250612","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41379-019-0279-8","article-title":"Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified","volume":"33","author":"Laginestra","year":"2020","journal-title":"Mod Pathol"},{"key":"R12-20250612","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1182\/blood-2017-04-777029","article-title":"DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions","volume":"130","author":"Buscarlet","year":"2017","journal-title":"Blood"},{"key":"R13-20250612","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1182\/blood-2012-02-408542","article-title":"Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters","volume":"120","author":"Lemonnier","year":"2012","journal-title":"Blood"},{"key":"R14-20250612","doi-asserted-by":"crossref","first-page":"4014","DOI":"10.1002\/cncr.26724","article-title":"NRAS mutation status is an independent prognostic factor in metastatic melanoma","volume":"118","author":"Jakob","year":"2012","journal-title":"Cancer"},{"key":"R15-20250612","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1038\/s41598-017-04948-3","article-title":"BRAF and NRAS mutations in papillary thyroid carcinoma and concordance in BRAF mutations between primary and corresponding lymph node metastases","volume":"7","author":"Fakhruddin","year":"2017","journal-title":"Sci Rep"},{"key":"R16-20250612","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"Tyner","year":"2018","journal-title":"Nature"},{"key":"R17-20250612","doi-asserted-by":"crossref","first-page":"12152","DOI":"10.1038\/s41598-020-69194-6","article-title":"Mutational spectrum and prognosis in NRAS-mutated acute myeloid leukemia","volume":"10","author":"Wang","year":"2020","journal-title":"Sci Rep"},{"key":"R18-20250612","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1038\/s41467-021-23186-w","article-title":"RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis","volume":"12","author":"Carr","year":"2021","journal-title":"Nat Commun"},{"key":"R19-20250612","doi-asserted-by":"crossref","first-page":"e26786","DOI":"10.1002\/pbc.26786","article-title":"Mutational status of NRAS, KRAS, and PTPN11 genes is associated with genetic\/cytogenetic features in children with B-precursor acute lymphoblastic leukemia","volume":"65","author":"Liang","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"R20-20250612","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1038\/s41375-019-0444-6","article-title":"KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival","volume":"33","author":"Vendramini","year":"2019","journal-title":"Leukemia"},{"key":"R21-20250612","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1200\/JCO.2014.59.1503","article-title":"Mutational spectrum, copy number changes, and outcome: results of a sequencing study of patients with newly diagnosed myeloma","volume":"33","author":"Walker","year":"2015","journal-title":"J Clin Oncol"},{"key":"R22-20250612","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.3389\/fonc.2019.01137","article-title":"KRAS\/NRAS\/BRAF mutations as potential targets in multiple myeloma","volume":"9","author":"Pasca","year":"2019","journal-title":"Front Oncol"},{"key":"R23-20250612","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41586-019-1012-y","article-title":"Efficacy of MEK inhibition in patients with histiocytic neoplasms","volume":"567","author":"Diamond","year":"2019","journal-title":"Nature"},{"key":"R24-20250612","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1242\/jcs.182873","article-title":"RAS isoforms and mutations in cancer at a glance","volume":"129","author":"Hobbs","year":"2016","journal-title":"J Cell Sci"},{"key":"R25-20250612","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1470-2045(17)30180-8","article-title":"Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial","volume":"18","author":"Dummer","year":"2017","journal-title":"Lancet Oncol"},{"key":"R26-20250612","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1038\/leu.2014.200","article-title":"Frequent STAT5B mutations in gammadelta hepatosplenic T-cell lymphomas","volume":"28","author":"Nicolae","year":"2014","journal-title":"Leukemia"},{"key":"R27-20250612","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1158\/2159-8290.CD-16-0330","article-title":"The genetic basis of hepatosplenic T-cell lymphoma","volume":"7","author":"McKinney","year":"2017","journal-title":"Cancer Discov"},{"key":"R28-20250612","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1038\/ncomms7025","article-title":"Activating mutations of STAT5B and STAT3 in lymphomas derived from gammadelta-T or NK cells","volume":"6","author":"Kucuk","year":"2015","journal-title":"Nat Commun"},{"key":"R29-20250612","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/leu.2016.13","article-title":"JAK-STAT and G-protein-coupled receptor signaling pathways are frequently altered in epitheliotropic intestinal T-cell lymphoma","volume":"30","author":"Nairismagi","year":"2016","journal-title":"Leukemia"},{"key":"R30-20250612","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3324\/haematol.2009.014050","article-title":"C\/EBPbeta expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathway","volume":"95","author":"Anastasov","year":"2010","journal-title":"Haematologica"},{"key":"R31-20250612","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ccell.2015.03.006","article-title":"Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma","volume":"27","author":"Crescenzo","year":"2015","journal-title":"Cancer Cell"},{"key":"R32-20250612","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1038\/ng.3415","article-title":"Integrated molecular analysis of adult T cell leukemia\/lymphoma","volume":"47","author":"Kataoka","year":"2015","journal-title":"Nat Genet"},{"key":"R33-20250612","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1158\/2159-8290.CD-12-0028","article-title":"Janus kinase 3-activating mutations identified in natural killer\/T-cell lymphoma","volume":"2","author":"Koo","year":"2012","journal-title":"Cancer Discov"},{"key":"R34-20250612","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/leu.2013.157","article-title":"JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma","volume":"28","author":"Bouchekioua","year":"2014","journal-title":"Leukemia"},{"key":"R35-20250612","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 mutations in large granular lymphocytic leukemia","volume":"366","author":"Koskela","year":"2012","journal-title":"N Engl J Med"},{"key":"R36-20250612","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1182\/blood-2012-06-435297","article-title":"STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia","volume":"120","author":"Jerez","year":"2012","journal-title":"Blood"},{"key":"R37-20250612","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2014-03-559542","article-title":"Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia","volume":"124","author":"Kiel","year":"2014","journal-title":"Blood"},{"key":"R38-20250612","doi-asserted-by":"crossref","first-page":"12602","DOI":"10.1038\/ncomms12602","article-title":"Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations","volume":"7","author":"Roberti","year":"2016","journal-title":"Nat Commun"},{"key":"R39-20250612","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nature10725","article-title":"The genetic basis of early T-cell precursor acute lymphoblastic leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"R40-20250612","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3324\/haematol.2015.130179","article-title":"Targeted sequencing identifies associations between IL7R-JAK mutations and epigenetic modulators in T-cell acute lymphoblastic leukemia","volume":"100","author":"Vicente","year":"2015","journal-title":"Haematologica"},{"key":"R41-20250612","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/gcc.22141","article-title":"Recurrent mutation of JAK3 in T-cell prolymphocytic leukemia","volume":"53","author":"Bergmann","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"R42-20250612","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1038\/onc.2010.117","article-title":"Array-based genomic resequencing of human leukemia","volume":"29","author":"Yamashita","year":"2010","journal-title":"Oncogene"},{"key":"R43-20250612","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/modpathol.2009.196","article-title":"CDKN2A-CDKN2B deletion defines an aggressive subset of cutaneous T-cell lymphoma","volume":"23","author":"Laharanne","year":"2010","journal-title":"Mod Pathol"},{"key":"R44-20250612","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/his.13223","article-title":"Clinicopathological analysis of primary central nervous system NK\/T cell lymphoma: rare and localized aggressive tumour among extranasal NK\/T cell tumours","volume":"71","author":"Miyata-Takata","year":"2017","journal-title":"Histopathology"},{"key":"R45-20250612","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/modpathol.3800157","article-title":"Nasal-type extranodal natural killer\/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore","volume":"17","author":"Ng","year":"2004","journal-title":"Mod Pathol"},{"key":"R46-20250612","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.humpath.2006.01.032","article-title":"Primary extranodal nasal-type natural killer\/T-cell lymphoma of the brain: a case report","volume":"37","author":"Kaluza","year":"2006","journal-title":"Hum Pathol"},{"key":"R47-20250612","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s11060-010-0384-5","article-title":"Primary central nervous system extranodal NK\/T-cell lymphoma, nasal type: case report and review of the literature","volume":"103","author":"Guan","year":"2011","journal-title":"J Neurooncol"},{"key":"R48-20250612","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1200\/JCO.2012.47.6796","article-title":"Primary CNS natural killer\/T-cell lymphoma of the nasal type presenting in a woman: case report and review of the literature","volume":"32","author":"Prajapati","year":"2014","journal-title":"J Clin Oncol"},{"key":"R49-20250612","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jns.2014.05.015","article-title":"Primary natural killer\/T-cell lymphoma presenting as leptomeningeal disease","volume":"343","author":"Liao","year":"2014","journal-title":"J Neurol Sci"},{"key":"R50-20250612","doi-asserted-by":"crossref","first-page":"1176.e1175","DOI":"10.1016\/j.wneu.2015.06.063","article-title":"Primary central nervous system natural killer cell lymphoma in a chinese woman with atypical (11)C-choline positron emission tomography and magnetic resonance spectrometry findings","volume":"84","author":"Li","year":"2015","journal-title":"World Neurosurg"},{"key":"R51-20250612","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/gcc.22348","article-title":"Frequent BCOR aberrations in extranodal NK\/T-Cell lymphoma, nasal type","volume":"55","author":"Dobashi","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"key":"R52-20250612","doi-asserted-by":"crossref","first-page":"17764","DOI":"10.18632\/oncotarget.3776","article-title":"Genetic alterations of JAK\/STAT cascade and histone modification in extranodal NK\/T-cell lymphoma nasal type","volume":"6","author":"Lee","year":"2015","journal-title":"Oncotarget"},{"key":"R53-20250612","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1038\/sj.onc.1205571","article-title":"Frequent mutations of Fas gene in nasal NK\/T cell lymphoma","volume":"21","author":"Takakuwa","year":"2002","journal-title":"Oncogene"},{"key":"R54-20250612","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1016\/S0002-9440(10)64490-2","article-title":"Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer\/T-cell lymphoma","volume":"161","author":"Shen","year":"2002","journal-title":"Am J Pathol"},{"key":"R55-20250612","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000492835","article-title":"Frequent mutations in natural killer\/T cell lymphoma","volume":"49","author":"Zhang","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"R56-20250612","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13045-019-0716-7","article-title":"Molecular pathogenic pathways in extranodal NK\/T cell lymphoma","volume":"12","author":"de Mel","year":"2019","journal-title":"J Hematol Oncol"},{"key":"R57-20250612","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/leu.2009.3","article-title":"Genomic analyses reveal global functional alterations that promote tumor growth and novel tumor suppressor genes in natural killer-cell malignancies","volume":"23","author":"Iqbal","year":"2009","journal-title":"Leukemia"},{"key":"R58-20250612","doi-asserted-by":"crossref","first-page":"20119","DOI":"10.1073\/pnas.1115128108","article-title":"PRDM1 is a tumor suppressor gene in natural killer cell malignancies","volume":"108","author":"Kucuk","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R59-20250612","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ccell.2020.02.005","article-title":"Genomic and transcriptomic characterization of natural killer T cell lymphoma","volume":"37","author":"Xiong","year":"2020","journal-title":"Cancer Cell"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001859","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T17:00:57Z","timestamp":1749747657000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001859"}},"subtitle":["An Analysis of 11 Cases Using Targeted Gene Sequencing"],"short-title":[],"issued":{"date-parts":[[2022,1,3]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001859","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,3]]}}}